Skip to main content
Marc-David Ruepp

Dr Marc-David Ruepp Priv-Doz, PhD

Reader in RNA Biology and Molecular Neurodegeneration

Research interests

  • Neuroscience

Biography

I am a ribonucleic acid (RNA) Biochemist interested in gene expression in health and disease with a specific focus on dysfunctional RNA metabolism in neurodegeneration. My main research objective is to uncover the impact and contribution of altered RNA metabolism on selective neuronal death in amyotrophic lateral sclerosis and fronto-temporal dementia. Apart from my position as Senior Lecturer at King’s College London, I am also a fellow of the United Kingdom Dementia Research Institute and currently one of the Academic Mentors for the PhD students in the Department of Basic & Clinical Neuroscience.

Please see my Research Staff Profile for more detail.

Key Collaborators:

  • Professor Chris Shaw, King's College London
  • Dr. Caroline Vance, King's College London
  • Professor Frederic Allain, ETH Zuerich
  • Dr. Sarah Mizielinska, King's College London

Research

synthetic-biology
RNA Biology

RNA is at the forefront of biomedical research for its central role in how information is transferred from DNA to protein. This Research Interest Group is open to all interested parties from across the University.

News

Over £1.4 million awarded to King's researchers to accelerate MND treatment development

Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards...

MND Accelerator awards 2024

Breakthrough disease mechanism behind Amyotrophic Lateral Sclerosis (ALS) uncovered

Researchers at UK Dementia Research Institute at King’s College London and ETH Zürich found a new role for RNA in the development of a neurodegenerative...

Brain jigsaw with a puzzle piece taken out and laid next to it

Research

synthetic-biology
RNA Biology

RNA is at the forefront of biomedical research for its central role in how information is transferred from DNA to protein. This Research Interest Group is open to all interested parties from across the University.

News

Over £1.4 million awarded to King's researchers to accelerate MND treatment development

Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards...

MND Accelerator awards 2024

Breakthrough disease mechanism behind Amyotrophic Lateral Sclerosis (ALS) uncovered

Researchers at UK Dementia Research Institute at King’s College London and ETH Zürich found a new role for RNA in the development of a neurodegenerative...

Brain jigsaw with a puzzle piece taken out and laid next to it